Email Updates

Search form

You are here

HIV vaccine to begin human trials in 2019

Include in
Media Coverage

A new experimental vaccine regimen, tailor made to fit of the structure of a vulnerable region on HIV, generated antibodies in mice, guinea pigs and monkeys, and it neutralized dozens of HIV strains. The findings will lead to human clinical trials for a vaccine capable of neutralizing a large fraction of common HIV strains.

June 21, 2018